enGene Therapeutics Inc. Common Stock
$1.96
▲ +0.04
(+2.08%)
Volume: 1,976,101
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
62
- 21d momentum +0.5%
- MA aligned bullish
- RSI 56
🎯
Pullback
38
- Near upper Bollinger band
- +3.7% vs 20MA
💎
Value
58
- -84% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)55.7
MACD+0.009
MA trendBullish
ATR4.00%
21d mom.+0.5%
63d mom.+12.0%
vs 20MA+3.7%
RVOL(20)3.13×
52w low · 1
52w high · 12
-84.0% from 52-week high
20d support 2
· resistance 2
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$129M
PER—
PBR0.56
PSR—
EPS$-1.95
ROE-56.6%
ROA-45.2%
Dividend yield0.00%
Debt/Equity0.11
EV/EBITDA-0.83
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +2.62% | +0.51% | +12.00% | -71.84% | -71.92% | -77.85% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum +7.69%, daily vol 3.09%. enGene Therapeutics Inc. Common Stock sits in a bullish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.